Litigation Details for Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2018)
✉ Email this page to a colleague
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-10-29 |
Court | District Court, D. Delaware | Date Terminated | 2019-03-04 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 9,566,289; 9,566,290; 9,572,823 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
Details for Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-10-29 | 1 | of U.S. Patent No. 9,459,938 (“the ’938 patent”); U.S. Patent No. 9,566,289 (“the ’289 patent”); U.S.…U.S. Patent No. 9,566,290 (“the ’290 patent”); and U.S. Patent No. 9,572,823 (“the ’823 patent”). These…the ’289 patent; claims 2, 5–6, 8, and 11–12 of the ’290 patent; and claim 2 of the ’823 patent. … 1. This is an action for patent infringement under the patent laws of the United States, Title…These four patents are referred to collectively herein as “the patents-in-suit.” 2. | External link to document | |
2019-03-03 | 29 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,459,938 B2; 9,566,289 B2; 9,566,290…2018 4 March 2019 1:18-cv-01699 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2018-10-29 | 3 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,459,938 B2 ;9,566,289 B2 ;9,566,290…2018 4 March 2019 1:18-cv-01699 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |